Key facts
- This page summarizes Rajeev A. Modi's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Feb 2025, 18:12.
Rajeev A. Modi - 19 Feb 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)
- Reporting relationship
- Executive Vice President U.S. Pet Health and Global Digital Transformation
- Issuer ticker
- ELAN
- Reported as of
- 19 Feb 2025
- Net transaction value
- -$210,604
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2025, 18:12:35 UTC
- Prior SEC filing
- 11 Feb 2025
- Next SEC filing
- 25 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rajeev A. Modi filed Form 4 for Elanco Animal Health Inc (ELAN) on 21 Feb 2025.
Change
- Previous filing in this sequence was filed on 11 Feb 2025.
- Current net transaction value: -$210,604.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELAN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +42,133
- Change %
- +59%
- Price
- $0.000000
- Shares after
- 113,356
- Date
- 19 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F2
ELAN
transaction
Common Stock
Tax liability
- Transaction value
- $210,604
- Shares
- -18,737
- Change %
- -17%
- Price
- $11.24
- Shares after
- 94,619
- Date
- 19 Feb 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Includes 1,276 shares acquired on April 30, 2024 and 466 shares acquired on July 31, 2024 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.
Footnote F2
Corrects the number of shares purchased under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022 by deducting 282 shares.
SEC remarks
Executive Vice President U.S. Pet Health and Global Digital Transformation